Healthinvest Partners Ab Top Holdings and 13F Report (2024) → A ‘DeFi Summer’ Projected! (From Crypto 101 Media) (Ad) About Healthinvest Partners AbInvestment ActivityHealthinvest Partners Ab has $164.35 million in total holdings as of March 31, 2024.Healthinvest Partners Ab owns shares of 44 different stocks, but just 21 companies or ETFs make up 80% of its holdings.Approximately 31.36% of the portfolio was purchased this quarter.About 16.77% of the portfolio was sold this quarter.This quarter, Healthinvest Partners Ab has purchased 45 new stocks and bought additional shares in 29 stocks.Healthinvest Partners Ab sold shares of 6 stocks and completely divested from 6 stocks this quarter.Largest Holdings Merck & Co., Inc. $17,647,125Eli Lilly and Company $16,164,453UnitedHealth Group $11,398,383Thermo Fisher Scientific $8,826,255Neurocrine Biosciences $5,996,762 Largest New Holdings this Quarter Mirum Pharmaceuticals $3,089,760 HoldingCorbus Pharmaceuticals $1,491,120 HoldingMacroGenics $725,799 HoldingNewAmsterdam Pharma $529,618 HoldingMersana Therapeutics $448,000 Holding Largest Purchases this Quarter Merck & Co., Inc. 68,066 shares (about $8.98M)Neurocrine Biosciences 30,863 shares (about $4.26M)Eli Lilly and Company 4,973 shares (about $3.87M)Option Care Health 95,672 shares (about $3.21M)Mirum Pharmaceuticals 123,000 shares (about $3.09M) Largest Sales this Quarter Cencora 18,499 shares (about $4.50M)Gilead Sciences 46,974 shares (about $3.44M)Cardinal Health 20,500 shares (about $2.29M)Elevance Health 2,100 shares (about $1.09M)Molina Healthcare 500 shares (about $205.42K) Sector Allocation Over TimeMap of 500 Largest Holdings ofHealthinvest Partners Ab Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorMRKMerck & Co., Inc.$17,647,125$8,981,309 ▲103.6%133,74110.7%MedicalLLYEli Lilly and Company$16,164,453$3,868,795 ▲31.5%20,7789.8%MedicalUNHUnitedHealth Group$11,398,383$2,291,945 ▲25.2%23,0416.9%MedicalTMOThermo Fisher Scientific$8,826,255$2,191,743 ▲33.0%15,1865.4%MedicalNBIXNeurocrine Biosciences$5,996,762$4,256,625 ▲244.6%43,4803.6%MedicalHRMYHarmony Biosciences$5,708,600$839,500 ▲17.2%170,0003.5%MedicalSYKStryker$5,423,162$841,710 ▲18.4%15,1543.3%MedicalAMGNAmgen$5,371,089$815,430 ▲17.9%18,8913.3%MedicalABBVAbbVie$5,343,907$1,484,115 ▲38.5%29,3463.3%MedicalBSXBoston Scientific$5,301,194$862,631 ▲19.4%77,4013.2%MedicalREGNRegeneron Pharmaceuticals$5,190,709$1,360,961 ▲35.5%5,3933.2%MedicalCORCencora$4,963,314$4,495,072 ▼-47.5%20,4263.0%MedicalMOHMolina Healthcare$4,929,960$205,415 ▼-4.0%12,0003.0%MedicalVRTXVertex Pharmaceuticals$4,721,423$904,992 ▲23.7%11,2952.9%MedicalOPCHOption Care Health$4,457,298$3,208,839 ▲257.0%132,8952.7%MedicalELVElevance Health$3,837,196$1,088,934 ▼-22.1%7,4002.3%MedicalGILDGilead Sciences$3,809,000$3,440,846 ▼-47.5%52,0002.3%MedicalDXCMDexCom$3,645,452$1,140,946 ▲45.6%26,2832.2%MedicalMIRMMirum Pharmaceuticals$3,089,760$3,089,760 ▲New Holding123,0001.9%MedicalCAHCardinal Health$3,077,250$2,293,950 ▼-42.7%27,5001.9%MedicalFOLDAmicus Therapeutics$2,972,176$2,398,372 ▲418.0%252,3071.8%MedicalFUSNFusion Pharmaceuticals$2,959,984$294,984 ▲11.1%138,8361.8%MedicalIONSIonis Pharmaceuticals$2,765,340$1,714,406 ▲163.1%63,7911.7%MedicalIMCRImmunocore$2,658,435$2,149,940 ▲422.8%40,8991.6%MedicalITCIIntra-Cellular Therapies$2,633,060$1,785,706 ▲210.7%38,0501.6%MedicalIQVIQVIA$2,543,568$71,315 ▼-2.7%10,0581.5%MedicalEWEdwards Lifesciences$2,367,499$378,418 ▲19.0%24,7751.4%MedicalSWAVShockwave Medical$1,547,068$397,594 ▲34.6%4,7510.9%MedicalCRBPCorbus Pharmaceuticals$1,491,120$1,491,120 ▲New Holding38,0000.9%MedicalCABACabaletta Bio$1,322,832$964,572 ▲269.2%77,5400.8%MedicalACLXArcellx$1,216,847$423,977 ▲53.5%17,4960.7%MedicalKRYSKrystal Biotech$1,178,6080.0%6,6240.7%MedicalBBIOBridgeBio Pharma$1,170,044$428,428 ▲57.8%37,8410.7%MedicalEXASExact Sciences$1,113,247$273,685 ▲32.6%16,1200.7%MedicalMRUSMerus$1,095,3550.0%24,3250.7%MedicalINSPInspire Medical Systems$1,027,126$333,569 ▲48.1%4,7820.6%MedicalCYTKCytokinetics$981,540$158,939 ▲19.3%14,0000.6%MedicalMDGLMadrigal Pharmaceuticals$945,055$269,176 ▲39.8%3,5390.6%MedicalMGNXMacroGenics$725,799$725,799 ▲New Holding49,3070.4%MedicalAKROAkero Therapeutics$617,152$227,340 ▲58.3%24,4320.4%MedicalAUTLAutolus Therapeutics$614,6810.0%96,3450.4%MedicalNAMSNewAmsterdam Pharma$529,618$529,618 ▲New Holding22,3940.3%MedicalMORFMorphic$526,3100.0%14,9520.3%MedicalMRSNMersana Therapeutics$448,000$448,000 ▲New Holding100,0000.3%MedicalCNCCentene$0$4,601,020 ▼-100.0%00.0%MedicalBMYBristol-Myers Squibb$0$4,515,280 ▼-100.0%00.0%MedicalCIThe Cigna Group$0$4,491,750 ▼-100.0%00.0%MedicalPFEPfizer$0$1,232,788 ▼-100.0%00.0%MedicalAMBRX BIOPHARMA INC$0$823,741 ▼-100.0%00.0%COMPRTAProthena$0$303,148 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data: SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.